Hans-Dieter Klenk
Klenk, Hans-Dieter, 1938-....
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
Klenk, Hans-Dieter 1938-2021
Klenk, Hans-Dieter
Klenk, H.-D. (Hans-Dieter), 1938-
Klenk, H.-D. (Hans-Dieter)
VIAF ID: 49378364 (Personal)
Permalink: http://viaf.org/viaf/49378364
Preferred Forms
-
100 0 _
‡a
Hans-Dieter Klenk
-
200 _ 1 ‡a Klenk ‡b Hans-Dieter ‡f 1938-
-
200 _ |
‡a
Klenk
‡b
Hans-Dieter
‡f
1938-....
-
100 1 _
‡a
Klenk, H.-D.
‡q
(Hans-Dieter)
-
100 1 _
‡a
Klenk, H.-D.
‡q
(Hans-Dieter),
‡d
1938-
-
100 1 _ ‡a Klenk, H.-D. ‡q (Hans-Dieter), ‡d 1938-
-
100 1 _ ‡a Klenk, Hans-Dieter
-
100 1 _ ‡a Klenk, Hans-Dieter
-
100 1 _ ‡a Klenk, Hans-Dieter ‡d (1938- ).
-
100 1 _ ‡a Klenk, Hans-Dieter ‡d (1938-2021)
-
100 1 _
‡a
Klenk, Hans-Dieter
‡d
1938-
-
100 1 _
‡a
Klenk, Hans-Dieter
‡d
1938-2021
-
100 1 _ ‡a Klenk, Hans-Dieter, ‡d 1938-
-
100 1 _
‡a
Klenk, Hans-Dieter,
‡d
1938-....
4xx's: Alternate Name Forms (16)
5xx's: Related Names (2)
- 551 _ _
‡a
Institut für Virologie, Universitätsklinikum Gießen und Marburg, Standort Marburg
‡4
ortw
‡4
https://d-nb.info/standards/elementset/gnd#placeOfActivity
- 551 _ _
‡a
Köln
‡4
ortg
‡4
https://d-nb.info/standards/elementset/gnd#placeOfBirth
Works
| Title | Sources |
|---|---|
| Avian influenza |
|
| Influenza A Virus Replication Induces Cell Cycle Arrest in G 0 /G 1 Phase |
|
| Influenzaforschung und das Dual-Use-Problem |
|
| Lassa Virus Z Protein Is a Matrix Protein and Sufficient for the Release of Virus-Like Particles. |
|
| Lipoidzusammensetzung von normalen und pathologischen Lebern des Menschen |
|
| Marburg and Ebola viruses |
|
| Modern trends in virology, c1988: |
|
| A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products |
|
| NP gene of pandemic H1N1 virus attenuates virulence of mouse-adapted human influenza virus |
|
| Oligomerization and polymerization of the filovirus matrix protein VP40. |
|
| Options for the control of influenza II : proceedings of the International Conference on Options for the Control of Influenza, Courchevel, 27 September-2 October 1992 |
|
| Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium |
|
| Phosphorylation of VP30 impairs ebola virus transcription |
|
| Phylogeny of the SARS coronavirus. |
|
| Plasma membrane lipids and parainfluenza virus assembly |
|
| Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus. |
|
| Polarized budding of measles virus is not determined by viral surface glycoproteins. |
|
| Polarized glycoprotein targeting affects the spread of measles virus in vitro and in vivo |
|
| Polymer-bound 6' sialyl-N-acetyllactosamine protects mice infected by influenza virus |
|
| Polymerase chain reaction detection of Puumala virus RNA in formaldehyde-fixed biopsy material |
|
| Possible involvement of microtubule disruption in bipolar budding of a Sendai virus mutant, F1-R, in epithelial MDCK cells. |
|
| Post-translational folding of the influenza C virus glycoprotein HEF: defective processing in cells expressing the cloned gene |
|
| Post-translational glycosylation of coronavirus glycoprotein E1: inhibition by monensin |
|
| Post-translational modifications in insect cells. |
|
| Presence of murine leukemia virus envelope proteins gp70 and p15(E) in a common polyprotein of infected cells |
|
| Processing and localisation of a GPI-anchored Plasmodium falciparum surface protein expressed by the baculovirus system |
|
| Processing and routage of HIV glycoproteins by furin to the cell surface |
|
| Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses |
|
| Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium |
|
| Proteolytic activation of the influenza virus hemagglutinin: The structure of the cleavage site and the enzymes involved in cleavage |
|
| Proteolytic cleavage of the viral glycoproteins and its significance for the virulence of Newcastle disease virus |
|
| Proteolytic cleavage of wild type and mutants of the F protein of human parainfluenza virus type 3 by two subtilisin-like endoproteases, furin and Kex2. |
|
| Proteolytic processing of human cytomegalovirus glycoprotein B (gpUL55) is mediated by the human endoprotease furin. |
|
| Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification |
|
| Rat alpha 1 macroglobulin inhibits hemagglutination by influenza C virus |
|
| Reaction of viruses and virus-infected cells with heterophile agglutinins |
|
| Receptor-binding properties of influenza viruses isolated from gulls |
|
| Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes |
|
| Recombinant measles virus requiring an exogenous protease for activation of infectivity |
|
| Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity |
|
| Recycling of furin from the plasma membrane. Functional importance of the cytoplasmic tail sorting signals and interaction with the AP-2 adaptor medium chain subunit |
|
| Regulation of fusion activity by the cytoplasmic domain of a paramyxovirus F protein |
|
| Release of viral glycoproteins during Ebola virus infection |
|
| Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease |
|
| Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30 |
|
| Rescue of vector-expressed fowl plague virus hemagglutinin in biologically active form by acidotropic agents and coexpressed M2 protein |
|
| Retarded processing of influenza virus hemagglutinin in insect cells |
|
| The role of eukaryotic subtilisin-like endoproteases for the activation of human immunodeficiency virus glycoproteins in natural host cells |
|
| Role of Staphylococcus protease in the development of influenza pneumonia |
|
| Role of the M2 protein in influenza virus membrane fusion: effects of amantadine and monensin on fusion kinetics |
|
| SARS--beginning to understand a new virus |
|
| SARS vaccine protective in mice |
|
| The Spread of a Pathogenic and an Apathogenic Strain of Newcastle Disease Virus in the Chick Embryo as Depending on the Protease Sensitivity of the Virus Glycoproteins |
|
| The structure and function of paramyxovirus glycoproteins |
|
| Struktur und Biosynthese von Virusmembranen |
|
| The surface receptor is a major determinant of the cell tropism of influenza C virus |
|
| The synergies of microorganisms enlightened - convergent approaches to delineating coinfections |
|
| Threat of infection : microbes of high pathogenic potential - strategies for detection, control and eradication : International Symposium, Würzburg, July 25 to 28, 2004 / ed. Jörg Hacker, Hans-Dieter Klenk. - Stuttgart, 2005. |
|
| Transfer of an esterase-resistant receptor analog to the surface of influenza C virions results in reduced infectivity due to aggregate formation |
|
| Transmission studies resume for avian flu. |
|
| Ubiquitous activation of the Nipah virus fusion protein does not require a basic amino acid at the cleavage site |
|
| Understanding influenza virus pathogenicity |
|
| Use of a sialic acid analogue to analyze the importance of the receptor-destroying enzyme for the interaction of influenza C virus with cells |
|
| VACCINES. Ebola virus vaccines--preparing for the unexpected |
|
| Variations in glycosylation of the influenza virus hemagglutinin of subtype H7. Brief report |
|
| Viral Envelopes and Their Relationship to Cellular Membranes |
|
| Viral glycoprotein metabolism as a target for antiviral substances |
|
